Cargando…

Adverse Cardiovascular Events Associated With Cyclin‐Dependent Kinase 4/6 Inhibitors in Patients With Metastatic Breast Cancer

BACKGROUND: Cyclin‐dependent kinase (CDK) 4 and 6 inhibitors have significantly improved survival in patients with hormone receptor–positive metastatic breast cancer. There are few data regarding the epidemiology of cardiovascular adverse events (CVAEs) with these therapies. METHODS AND RESULTS: Usi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fradley, Michael G., Nguyen, Nam H. K., Madnick, David, Chen, Yiqing, DeMichele, Angela, Makhlin, Igor, Dent, Susan, Lefebvre, Benedicte, Carver, Joseph, Upshaw, Jenica N., DeRemer, David, Ky, Bonnie, Guha, Avirup, Gong, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356048/ https://www.ncbi.nlm.nih.gov/pubmed/37301767 http://dx.doi.org/10.1161/JAHA.123.029361

Ejemplares similares

Racial and Ethnic Differences in Cardiac Surveillance Evaluation of Patients Treated With Anthracycline‐Based Chemotherapy
por: DeRemer, David L., et al.
Publicado: (2023)

Developing a Clinical Cardio-Oncology Program and the Building Blocks for Success: JACC: CardioOncology How To
por: Fradley, Michael G., et al.
Publicado: (2023)

Trastuzumab deruxtecan: An antibody-drug conjugate embracing its destiny in breast cancer
por: Makhlin, Igor, et al.
Publicado: (2022)

Clinically Relevant Drug Interactions in the Cancer Setting
por: DeRemer, David
Publicado: (2022)

Paraoxonase-1 Activity in Breast Cancer Patients Treated With Doxorubicin With or Without Trastuzumab
por: Thompson, Elizabeth W., et al.
Publicado: (2021)

Critical appraisal of nilotinib in frontline treatment of chronic myeloid leukemia
por: DeRemer, David L, et al.
Publicado: (2011)

Factors Influencing Prescribers' Decision for Extending Venous Thromboembolism Prophylaxis in the Medical Patient Population following Hospitalization
por: Ebied, Alex M., et al.
Publicado: (2020)

Management of Warfarin Anticoagulated Patients Choosing Hyperbaric Oxygen Treatments
por: DeRemer, Christina E., et al.
Publicado: (2019)

Collaboration Leads to Oral Chemotherapy Education
por: Glode, Ashley E., et al.
Publicado: (2018)

Targeting Cardiovascular Adverse Events of Metastatic Renal Cell Carcinoma Therapies
por: Guha, Avirup, et al.
Publicado: (2022)

Physical activity during and after breast cancer therapy and associations of baseline physical activity with changes in cardiac function by echocardiography
por: Upshaw, Jenica N., et al.
Publicado: (2020)

Cardiovascular adverse events associated with BRAF versus BRAF/MEK inhibitor: Cross‐sectional and longitudinal analysis using two large national registries
por: Guha, Avirup, et al.
Publicado: (2021)

Variability in the Calculation of Time in Therapeutic Range for the Quality Control Measurement of Warfarin
por: Siddiqui, Safia, et al.
Publicado: (2018)

Plerixafor Salvage Is Safe and Effective in Hard-to-Mobilize Patients Undergoing Chemotherapy and Filgrastim-Based Peripheral Blood Progenitor Cell Mobilization
por: Awan, Farrukh T., et al.
Publicado: (2012)

Newly diagnosed cardiovascular disease in patients treated with immune checkpoint inhibitors: a retrospective analysis of patients at an academic tertiary care center
por: Waheed, Nida, et al.
Publicado: (2021)

ROCK and Rolling Towards Predicting BCR-ABL Kinase Inhibitor-Induced Vascular Toxicity
por: Upshaw, Jenica N., et al.
Publicado: (2022)

T083: The Effect of Heart Failure on Management and Outcomes of Older Patients with Hodgkin Lymphoma
por: Upshaw, Jenica, et al.
Publicado: (2022)

Cardiovascular Toxicity of Novel HER2-Targeted Therapies in the Treatment of Breast Cancer
por: Dent, Susan F., et al.
Publicado: (2021)

How to Manage and Monitor Cardiac Dysfunction in Patients With Metastatic HER2-Positive Breast Cancer
por: Dent, Susan F., et al.
Publicado: (2022)

Editorial: Cancer treatment-related cardiovascular disease - real world data in cardio-oncology
por: Agarwala, Vivek, et al.
Publicado: (2023)

Impact of an ambulatory care pharmacist on provider relative value units in a rural clinic
por: DeRemer, Christina E., et al.
Publicado: (2021)

Health care utilization and mortality associated with heart failure‐related admissions among cancer patients
por: Guha, Avirup, et al.
Publicado: (2019)

A scoping review on the relationship between race/ethnicity and the receipt of supportive care medications during cancer treatment: Implications for the clinical pharmacist
por: Awunti, MegCholack, et al.
Publicado: (2022)

#JACCCardioOnc: Evolution of a Dedicated Social Media Strategy for JACC: CardioOncology
por: Brown, Sherry-Ann, et al.
Publicado: (2021)

Length of stay and cost of care associated with admissions for atrial fibrillation among patients with cancer
por: Guha, Avirup, et al.
Publicado: (2022)

The Association of Metformin With Heart Failure in Patients With Diabetes Mellitus Receiving Anthracycline Chemotherapy
por: Onoue, Takeshi, et al.
Publicado: (2023)

Proceedings From the Global Cardio-Oncology Summit: The Top 10 Priorities to Actualize for CardioOncology
por: Lenihan, Daniel J., et al.
Publicado: (2019)

Targeting Src-mediated Tyr216 phosphorylation and activation of GSK-3 in prostate cancer cells inhibit prostate cancer progression in vitro and in vivo
por: Goc, Anna, et al.
Publicado: (2014)

Cardio‐Oncology in the Era of the COVID‐19 Pandemic and Beyond
por: Addison, Daniel, et al.
Publicado: (2020)

Treatment with Piribedil and Memantine Reduces Noise-Induced Loss of Inner Hair Cell Synaptic Ribbons
por: Altschuler, Richard A., et al.
Publicado: (2016)

How to Manage Patients With Cardiac Implantable Electronic Devices Undergoing Radiation Therapy
por: Fradley, Michael G., et al.
Publicado: (2021)

Review of genetic and pharmacogenetic differences in cytotoxic and targeted therapies for pancreatic cancer in African Americans
por: Telisnor, Guettchina, et al.
Publicado: (2023)

Unraveling Racial Disparities in Supportive Care Medication Use among End-of-Life Pancreatic Cancer Patients: Focus on Pain Management and Psychiatric Therapies
por: Allen, John M., et al.
Publicado: (2023)

Lactate Dehydrogenase B and Pyruvate Oxidation Pathway Associated With Carfilzomib-Related Cardiotoxicity in Multiple Myeloma Patients: Result of a Multi-Omics Integrative Analysis
por: Tantawy, Marwa, et al.
Publicado: (2021)

Comparative effectiveness and safety of direct oral anticoagulants versus warfarin among patients with recurrent venous thromboembolism
por: Kang, Hye‐Rim, et al.
Publicado: (2023)

Quantum computation at the edge of a disordered Kitaev honeycomb lattice
por: Timoshuk, Igor, et al.
Publicado: (2023)

Comparative effectiveness and safety of extended anticoagulant therapy among Medicare beneficiaries with venous thromboembolism
por: Park, Haesuk, et al.
Publicado: (2022)

Social Determinants of Health Data Improve the Prediction of Cardiac Outcomes in Females with Breast Cancer
por: Stabellini, Nickolas, et al.
Publicado: (2023)

Comment on: Incidence of Adverse Psychiatric Events During the Treatment of Inflammatory Bowel Disease With Biologic Therapies: A Systematic Review
por: Salwen-Deremer, Jessica K, et al.
Publicado: (2019)

The Decrease in Hospitalizations For Heart Failure During the Covid-19 Pandemic: A Community and Academic Hospital Comparison Study
por: Vest, Amanda R., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_acmtidj4r4stl39ogo1aoe4imc